Clinical Trials Directory

Trials / Conditions / Early Stage Triple-Negative Breast Carcinoma

Early Stage Triple-Negative Breast Carcinoma

9 registered clinical trials studyying Early Stage Triple-Negative Breast Carcinoma — 7 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingPembrolizumab Adjuvant in Patients With Early-stage Triple Negative Breast Cancer With Residual Disease After
NCT07486687
The Netherlands Cancer InstitutePhase 3
RecruitingPersonalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative B
NCT06324240
Emory UniversityPhase 1
Active Not RecruitingPh2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial
NCT07407920
M.D. Anderson Cancer CenterPhase 2
RecruitingPhase II Trial of Ivonescimab in Combination With Carboplatin + Docetaxel in Patients With Early-Stage Triple
NCT07017673
Cedars-Sinai Medical CenterPhase 2
RecruitingTNBC Gut Microbiota During Neoadjuvant Treatment
NCT06610097
Scripps HealthN/A
RecruitingImmune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic Platform
NCT06349642
Mayo Clinic—
RecruitingShorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
NCT05929768
SWOG Cancer Research NetworkPhase 3
RecruitingPembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Respo
NCT05812807
Alliance for Clinical Trials in OncologyPhase 3
WithdrawnImplantable Microdevice for TNBC - Pilot Study
NCT05774886
Dana-Farber Cancer InstitutePhase 1